Pulmonary Associates of Richmond | West Broad

Research site

(Unclaimed)

Location

6600 West Broad Street Suite 300, Richmond, Virginia, United States of America

Site insights

Top conditions

Top treatments

Treprostinil

Levalbuterol

Racemic Albuterol

Seralutinib

Nintedanib

Sildenafil

SUN-101

(R,R)-Formoterol

Fluticasone

Olodaterol

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 44 total trials

Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) (SERANATA)

This Phase 3 study is designed as a 24-week randomized, double-blind, placebo-controlled period (PCP) followed by a 144-week long-term extension (LTE...

Enrolling

Pulmonary Hypertension Associated With Interstitial Lung Disease

Device: Generic Dry Powder Inhaler

Drug: Placebo

Locations recently updated

Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease (TETON-OLE)

Study RIN-PF-302 is designed to evaluate the long-term safety and tolerability of inhaled treprostinil in subjects with idiopathic pulmonary fibrosis...

Invitation-only

Progressive Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

Device: Treprostinil Ultrasonic Nebulizer

Drug: Inhaled Treprostinil

LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) (ELEVATE)

This study a randomized, double-blind, four arm study to evaluate the safety and efficacy of LYT-100 compared to pirfenidone or placebo in adults wit...

Active, not recruiting

Idiopathic Pulmonary Fibrosis

Drug: Deupirfenidone

Drug: Placebo

Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

This open-label extension study will evaluate the long-term safety, tolerability and efficacy of orally inhaled seralutinib in subjects who have comp...

Active, not recruiting

Pulmonary Arterial Hypertension

Device: Gereic Dry Powder Inhaler

Drug: Seralutinib

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)

Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FV...

Active, not recruiting

Idiopathic Pulmonary Fibrosis

Interstitial Lung Disease

Drug: Inhaled Treprostinil

Drug: Placebo

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a...

Enrolling

Progressive Pulmonary Fibrosis

Interstitial Lung Disease

Device: Treprostinil Ultrasonic Nebulizer

Drug: Placebo